Loosing my hairline at 29. 2 months on fina+mino
    10/9/2025

    From the encyclopedia
    Finasteride →

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    RU58841 →

    Experimental topical anti-androgen sold as a research chemical

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 2 months
    💧 Minoxidil (topical) 2 months
    the tone is 😐 neutral.

    Other terms

    A 29-year-old is experiencing hairline loss and has been using oral finasteride and topical minoxidil for two months, considering adding RU58841. They are advised to get a blood test for deficiencies and to style their hair instead of frequent haircuts.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research CLINICAL UPDATES IN HAIR

      19 citations , January 1997 in “Dermatologic Clinics”
      This chapter reviews various antiandrogens and androgen inhibitors, detailing their mechanisms, uses, and side effects, with a focus on spironolactone, finasteride, dutasteride, and oral contraceptives.

      research Alopecia - the search for novel agents continues

      11 citations , August 1997 in “Expert Opinion on Therapeutic Patents”
      This review discusses nearly 70 patent applications for the treatment of androgenetic alopecia and other hair conditions, highlighting the mechanisms of action explored but reports no clinical results.

      research Morphological Approach to Hair Disorders

      38 citations , June 2003 in “Journal of Investigative Dermatology Symposium Proceedings”
      This article reviews various topics discussed at a workshop on hair disorders, focusing on hair biology, diagnosis, and challenges in therapy evaluation, without presenting new clinical findings.

      research Hair growth and rejuvenation: An overview

      81 citations , June 2010 in “Journal of Dermatological Treatment”
      This review discusses recent advancements in hair rejuvenation strategies and assesses the potential of herbal drugs as safer alternatives, but reports no new clinical results.